scholarly journals Diabetic Patients’ Quality of Life and Their Relationship in Compliance with Antidiabetic Treatment. Case Study of Patients in a Public Hospital in Greece

2020 ◽  
Vol 17 ◽  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Diabetes Management ◽  
Medical Science ◽  
Diabetic Patients ◽  
Adherence To Treatment ◽  
Adherence To Medication ◽  
Antidiabetic Treatment

Background & Aim: Diabetes is a chronic disease that affects nearly half a million people worldwide. Although advances in technology and medical science have made diabetes management easier today, self-care and adherence to treatment (medication, diet, exercise, etc.) remain a major challenge for diabetic patients. The purpose of this study is to study the quality of life of patients with type 2 diabetes, their levels of compliance with antidiabetic treatment, and the relationship between the two. Methods & Materials: The present work followed the quantitative approach. A well-structured and reliable questionnaire used in a previous study was distributed to patients with type 2 diabetes mellitus. The results were analysed in SPSS statistical program and the correlation between antidiabetic treatment and quality of life was examined using Pearson coefficient. Results: The study involved 165 patients with type 2 diabetes who were hospitalized at the General Hospital of Messinia. Among the dimensions of adherence to treatment, only personal care behaviour (p <0.05) and adherence to care (p <0.05) were significantly and positively correlated with the physical quality of life health. Conclusion: Patients with type 2 diabetes have moderate the low quality of life, in line with previous research findings. Lower extremity care compliance was associated with the quality of life of diabetic patients with physical health, although previous studies have generally found that compliance with a diet regimen as well as adherence to medication is associated with the quality of life of diabetic patients. Future research needs to address the same issue by taking larger and more representative samples.

scholarly journals Effect of a Quality of Life Education Program on Psychological Well-Being and Adherence to Treatment of Diabetic Patients

2021 ◽  
Vol 31 (1) ◽  
pp. 61-67
Author(s):  
Faezeh Jahan ◽  
◽  
Saeed Nematolahi ◽  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Education Program ◽  
Well Being ◽  
Diabetic Patients ◽  
Adherence To Treatment ◽  
Psychological Well Being ◽  
Statistical Population

Introduction: Diabetes is a chronic disease with fatal health complications. Identifying the psychological factors that control this disease is very important, one of which is quality of life (QOL). Objective: This study aimed to investigate the effect of a QOL education program on psychological well-being (PWB) and adherence to treatment of patients with type 2 diabetes. Materials and Methods: This is a pilot study with a quasi-experimental design based on pretest and posttest phases. The statistical population consists of all diabetic patients referred to health centers in Semnan City, Iran during the 6months from March to September 2018.Of them,30 type 2 diabetes, aged 30-60 years (male and female) were selected based on the inclusion criteria and randomly assigned to the intervention and control groups. They were first assessed by using Hayes’s general adherence scale (GAS) and Ryff’s psychological well-being scale the short form (PWBS-SF).Then, the intervention group received QOL education in 12 sessions, once per week each for 90 min. Then, posttest assessments were carried out. The collected data were analyzed using MANCOVA. Results: The QOL education program significantly increased adherence to treatment (P= 0.005) and PWV and all its dimensions (autonomy, environmental mastery, personal growth, positive relations with others, be purposeful in life, self-acceptance) in patients (P = 0.005). Conclusion: Since diabetes is one of the chronic diseases that need constant care and there is no definitive and immediate treatment for it, increasing PWB and adherence to treatment in patients to control this disease by QOL education can be very effective.

scholarly journals The TELE-DD project on treatment nonadherence in the population with type 2 diabetes and comorbid depression

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Juan Francisco Roy ◽  
María Luisa Lozano del Hoyo ◽  
Fernando Urcola-Pardo ◽  
Alicia Monreal-Bartolomé ◽  
Diana Cecilia Gracia Ruiz ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Phase I ◽  
Clinical Depression ◽  
Point Prevalence ◽  
Diabetic Patients ◽  
Comorbid Depression ◽  
Shared Risk

AbstractDiabetic patients have increased depression rates, diminished quality of life, and higher death rates due to depression comorbidity or diabetes complications. Treatment adherence (TA) and the maintenance of an adequate and competent self-care are crucial factors to reach optimal glycaemic control and stable quality of life in these patients. In this report, we present the baseline population analyses in phase I of the TELE-DD project, a three-phased population-based study in 23 Health Centres from the Aragonian Health Service Sector II in Zaragoza, Spain. The objectives of the present report are: (1) to determine the point prevalence of T2D and clinical depression comorbidity and treatment nonadherence; (2) to test if HbA1c and LDL-C, as primary DM outcomes, are related to TA in this population; and (3) to test if these DM primary outcomes are associated with TA independently of shared risk factors for DM and depression, and patients’ health behaviours. A population of 7,271 patients with type-2 diabetes and comorbid clinical depression was investigated for inclusion. Individuals with confirmed diagnoses and drug treatment for both illnesses (n = 3340) were included in the current phase I. A point prevalence of 1.9% was found for the T2D-depression comorbidity. The prevalence of patients nonadherent to treatment for these diseases was 35.4%. Multivariate analyses confirmed that lower diabetes duration, increased yearly PCS visits, HbA1c and LDL-C levels were independently related to treatment nonadherence. These findings informed the development of a telephonic monitoring platform for treatment of nonadherence for people with diabetes and comorbid depression and further trial, cost-effectiveness, and prognostic studies (phases II and III).

scholarly journals The Health-Related Quality of Life of Vietnamese Type 2 Diabetic Patients

2020 ◽  
Vol 15 (2) ◽  
pp. 175-186
Author(s):  
Nghiep Ke Le ◽  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Family Type ◽  
Diabetic Patients ◽  
Health Related Quality ◽  
Life Score ◽  
Related Quality ◽  
Health Related

Type 2 diabetes is a chronic metabolic disorder that has serious complications including quality of life. This research analyses the health-related quality of life and the relative factors of type 2 diabetics in Tam Binh District, Vinh Long Province, Vietnam. A cross-sectional study was administered from July-August 2019 at seventeen communes in Tam Binh district. All total of 500 patients diagnosed type 2 diabetes and aged 35 years and older, comprised this investigation. The exploration questionnaire encompassed the Vietnamese Diabetes Quality of Life. Diabetics had an average age of 59.77 + 9.81 years. The health-related quality of life score was moderate at 60.15 + 21 points. The inter-personal relationship had the lowest score. However, the highest score was detected for the physical endurance. The significant differences could be distinguished at different individual components like age, marital status, location, family type, education, occupation, income, duration, glycaemia, HbA1c, hypoglycemia, alcohol-using, treatments, and other issues. The study highlighted that type 2 diabetes had a negative impact on health-related quality of life. Some patient characteristics affected Vietnamese diabetes quality of life score.

scholarly journals Assessment of medication adherence and quality of life among patients with type 2 diabetes mellitus in a tertiary hospital in Kelantan, Malaysia

2021 ◽  
Vol 1 (2) ◽  
pp. 79-86
Author(s):  
Nazmi Liana Azmi ◽  
Nurul Aida Md Rosly ◽  
Hock Chun Tang ◽  
Anis Fariha Che Darof ◽  
Nor Dini Zuki
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
Life Questionnaire ◽  
Adherence To Medication ◽  
The Mean

Introduction: Previous studies have reported the relationship between medication adherence and quality of life are interrelated. However, many of the results were found to be conflicting. This study aimed to assess the level and association of medication adherence and quality of life among type 2 diabetes mellitus patients in Raja Perempuan Zainab II Hospital, Kelantan, Malaysia. Materials and methods: A cross-sectional survey was conducted among adult type 2 diabetes mellitus patients on treatment for over 1 year using convenience sampling at outpatient.  Medication Compliance Questionnaire (MCQ) and revised Diabetes Quality of Life Questionnaire (DQOL) instrument were self-administered to eligible subjects. Data were analysed using GNU PSPP version 0.8.5 and reported for descriptive statistics as well as correlation of both parameters. Results: A total of 200 patients were recruited and they were mostly at the age of 40 to 60 years old. The mean (SD) score for MCQ was 26.0 (1.6) with the majority of them were non-adherent (55.0%, n=110). The mean (SD) score for overall revised DQOL instrument was 25.5 (8.9) while each domain of “satisfaction”, “impact” and “worry” had mean (SD) scores of 12.0 (5.0), 7.7 (3.4) and 5.9 (2.7), respectively. The scores obtained were only approximately half of the possible range of scores for QoL. There was no significant correlation between total score of medication adherence and quality of life when tested using Pearson’s correlation (r=-0.083, p=0.240). Independent t-test also demonstrated no significant relationship between medication adherence status and quality of life (p=0.883). Conclusion: Type 2 diabetes mellitus patients in our setting had unsatisfactory adherence but exhibited acceptable quality of life. We observed that both variables were not associated with one another. Further research is warranted to identify potential factors affecting non-adherence to medication.

scholarly journals Comparing effects of continuous glucose monitoring systems (CGMs) and self monitoring of blood glucose (SMBG) among adults with type 2 diabetes mellitus: A systematic review protocol

2020 ◽  
Author(s):  
Mingyue Zheng ◽  
Yunting Luo ◽  
Wei Lin ◽  
Adeel Khoja ◽  
Qian He ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Type 2 Diabetes ◽  
Blood Glucose ◽  
Glucose Control ◽  
Diabetes Management ◽  
Self Monitoring ◽  
Glucose Levels

Abstract Background: Continuous glucose monitors (CGMs) have been used to manage diabetes with reasonable glucose control among patients with type 2 diabetes (T2D) in recent decades. CGM systems measure interstitial fluid glucose levels to provide information about glucose levels, which identifies fluctuation that would not have been identified with conventional self-monitoring. Self-monitoring of blood glucose (SMBG) is a classical tool to achieve glycaemic control. However, the effectiveness of glucose control, costs, and quality of life are needed to evaluate and compare CGM and SMBG among adults with T2D.Methods: The review will compare the various forms of CGM systems (i.e flash-CGM, real-time-CGM, retrospective-CGM) versus SMBG/usual intervention regarding diabetes management among adults with T2D. The following databases will be searched: Cochrane Library, Science Direct, PubMed, EMBASE, CINAHL, PsycINFO, Scopus and grey literature for the identification of studies. The studies involving adults (aged ≥ 18 years old) will be included. We will include and summararize randomised clinical trials (RCTs) with respect to authors, publication type, year, status, and type of devices. Studies published in English between February 2010 and March 2020 will be included as the field of CGMs among T2D patients has emerged over the last decade. Primary outcomes that will be measured will be; HbA1c, body weight, time spent with hypoglycaemia or hyperglycaemia, blood pressure, quality of life. Secondary outcome measured will be morbidity, all-cause mortality, user satisfaction, and barriers. Study selection, data extraction, and risk of bias assessment will be conducted independently by at least two authors. A third author will determine and resolve discrepancies. Moreover, the quality of the evidence of the review will be assessed according to the Grading of Recommendations Assessment, Development and Evaluation Tool (GRADE).Discussion: The systematic review will synthesise evidence on the comparison between using CGMs and SMBG. The results will support researchers and health care professionals to determine the most effective methods/technologies in the overall diabetes management. Moreover, this review will provide more detailed information about the barriers of using CGMs to improve implementation.Systematic review registration: PROSPERO CRD42020149212

Perspectives of Fear as a Barrier to Self-Management in Non-Hispanic Black Men With Type 2 Diabetes

2018 ◽  
Vol 45 (6) ◽  
pp. 987-996 ◽  
Author(s):  
Ledric D. Sherman ◽  
Joni S. Williams
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Perceived Control ◽  
Diabetes Management ◽  
Phenomenological Approach ◽  
Self Management ◽  
Semistructured Interview ◽  
Self Monitoring

Background. Self-managing type 2 diabetes (T2D) is critical but often challenging for non-Hispanic Black (NHB) men. Fears may contribute to poor self-management; however, the evidence is sparse. The purpose of this study is to examine the relationship between fear and diabetes self-management in NHB men from the southern United States. Methods. Nineteen NHB men with T2D were recruited from barbershops and churches. Interviews were conducted using a semistructured interview guide. Transcripts were analyzed using a phenomenological approach and focused on identifying common themes describing the perceptions of fear as a barrier to self-managing T2D in the study participants. Results. More than 68% of the sample was >55 years of age, where 42% reported an annual income of ≥$100,000, 74% were married, and 26% had a college degree. Fifty-three percent expressed fear with diabetes management, while 47% reported no fears with diabetes management. Direct fears associated with self-management included the use of needles and syringes for self-monitoring and medication adherence, respectively. Indirect fears were associated with the development of adverse complications resulting in poor mental and physical quality of life. No fears were reported secondary to diabetes knowledge, perceived control, and social support. Conclusions. In this sample of NHB men, fear was perceived by many as a direct barrier to self-management and an indirect barrier to optimal quality of life. These findings suggest the need to address the fears of NHB men when guiding treatment and developing research interventions to improve self-management skills.

scholarly journals Instruments for Disease-Specific Quality-of-Life Measurement in Patients with Type 2 Diabetes Mellitus - A Systematic Review / Инструменты Для Оценки Специфического Качества Жизни Пациентов, Больных Сахарным Диабетом Типа 2

Folia Medica ◽  
2013 ◽  
Vol 55 (1) ◽  
pp. 83-92 ◽  
Author(s):  
Boryana A. Levterova ◽  
Donka D. Dimitrova ◽  
Georgi E. Levterov ◽  
Elena A. Dragova
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Well Being ◽  
Subjective Perception ◽  
Diabetic Patients ◽  
Disease Specific

Abstract Diabetes mellitus is a disease which carries a considerable social impact in Bulgaria and across the world because of its high prevalence. Research literature has recently included lots of studies investigating the effects of diabetes mellitus on the quality of life of diabetic patients and also many instruments to assess these effects. Quality of life is a concept that encompasses an individual‘s subjective perception of physical, emotional and social wellbeing, including both a cognitive component (satisfaction) and an emotional component (happiness). We review and analyse in the present article major determinants of disease-specific quality of life in patients with type 2 diabetes mellitus and the tools used for assessment. RESULTS: Fourteen instruments for measuring quality of life in type 2 diabetes mellitus (T2DM) met our search criteria. Their contents covered different quality-of-life domains or indicators - typical diabetes symptoms, general health and quality of life, personality traits, physical functioning, mental and social well-being, treatment and quality of life. Most of the disease-specific tools had been field tested and data about their reliability and validity have been reported. Few tools had been subjected to formal assessment of their adaptability to changes. CONCLUSIONS: Of the instruments we assessed the most promising approaches for measuring the diabetes-specific quality of life are offered by ADDQoL, DСP and WBQ. Patients were involved in the development of these tools which have been shown by a number of studies to have good internal reliability, external and construct validity. Efforts are being continually made worldwide to develop a standard ensuring valid, reliable, easy to use tool for assessing quality of life in patients with type 2 diabetes mellitus in order to promote patients integration into society.

scholarly journals Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A468-A468
Author(s):  
Aneesh Ghosh
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Diabetes Management ◽  
Diabetes Control ◽  
Value Systems ◽  
Diabetic Patients ◽  
Patient Centered ◽  
Oral Hypoglycaemic Agents

Abstract Background and Aims: WHO has defined quality of life as individuals perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. The quality of life evaluation is seen as an important aspect of care of diabetes mellitus 1. In this context it is imperative to study how new agents will affect the quality of life. In this study we have compared the quality of life of patients using dulaglutide and liraglutide. Deign and Method: We have used a simple self-administered patient centered quality of life (PCQoL) measure that is based on general and diabetes related life. This tool has shown to strongly correlate with the established reference scorings system, diabetes related quality of life (DQoL) score, developed for the Diabetes Control and Complications Trial 2,3. Sixty eligible patients on oral hypoglycaemic agents and Dulaglutide (N:30) or Liraglutide (N:30) formed the study group. All study subjects were on steady dose of GLP 1 RA for at least six months before they took two part quality of life (general and diabetes related) questionnaire during their hospital visit. In each part, subjects nominated five facets of life, judged to be important to them for quality of life (most important rated 5). Each aspect was then weighted by the patient for their current level of satisfaction on a five-point Likert scale (5, completely satisfied; 1, not at all satisfied), and a total score was calculated. Groups were matched for for age, sex, diabetes duration, comorbidities and HbA1C. The means were compared with Student’s t test. Results: The quality of life scores were better for dulaglutide than for liraglutide treated subjects (mean [SD] PCQoL: 66 [61–70] vs 56 [52 - 60], p &lt; 0.05). Discussion: In the diabetes management strategy, a primary therapeutic goal is to address and better the quality of life. In this study we have established that once weekly Dulaglutide offers better quality of life than daily injections of Liraglutide. PCQoL is a patient centered quality of life measurement is quick, simple, repeatable, sensitive, and valid in type 2 diabetes mellitus. References: 1.Rubin R, Peyrot M. Quality of life and diabetes. Diab Metab Res Rev. 1999;15(3):205–18. 2.Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med. 1993;329(14):977–86. 3.John C. Pickup, Anna Harris. Assessing Quality of Life for New Diabetes Treatments and Technologies: A Simple Patient-Centered Score. Journal of Diabetes Science and Technology. 2007;1(3):394–99.

Sign in / Sign up

Export Citation Format

Share Document